Drug General Information
Drug ID
D0N2AA
Former ID
DNC000109
Drug Name
8-aza-DADMe-ImmH
Drug Type
Small molecular drug
Indication Discovery agent Investigative [535759]
Structure
Download
2D MOL

3D MOL

Formula
C11H16N5O3+
Canonical SMILES
C1C(C(C[NH+]1CC2=C3C(=NN2)C(=O)N=CN3)O)CO
InChI
1S/C11H15N5O3/c17-4-6-1-16(3-8(6)18)2-7-9-10(15-14-7)11(19)13-5-12-9/h5-6,8,17-18H,1-4H2,(H,14,15)(H,12,13,19)/p+1
InChIKey
SLIJUTHLNPWRDL-UHFFFAOYSA-O
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Purine nucleoside phosphorylase Target Info Inhibitor [535759]
BioCyc Pathway Arsenate detoxification I (glutaredoxin)
Purine nucleotides degradation
Urate biosynthesis/inosine 5'-phosphate degradation
Purine deoxyribonucleosides degradation
Purine ribonucleosides degradation to ribose-1-phosphate
Guanosine nucleotides degradation
Adenosine nucleotides degradation
Superpathway of purine nucleotide salvage
Adenine and adenosine salvage III
Guanine and guanosine salvage
KEGG Pathway Purine metabolism
Pyrimidine metabolism
Nicotinate and nicotinamide metabolism
Metabolic pathways
NetPath Pathway TCR Signaling Pathway
EGFR1 Signaling Pathway
PANTHER Pathway Adenine and hypoxanthine salvage pathway
Xanthine and guanine salvage pathway
PathWhiz Pathway Purine Metabolism
Nicotinate and Nicotinamide Metabolism
Reactome Purine salvage
Purine catabolism
WikiPathways miR-targeted genes in squamous cell - TarBase
miR-targeted genes in lymphocytes - TarBase
miR-targeted genes in leukocytes - TarBase
miR-targeted genes in epithelium - TarBase
Metabolism of nucleotides
References
Ref 535759Achieving the ultimate physiological goal in transition state analogue inhibitors for purine nucleoside phosphorylase. J Biol Chem. 2003 Aug 22;278(34):31465-8. Epub 2003 Jul 3.
Ref 535759Achieving the ultimate physiological goal in transition state analogue inhibitors for purine nucleoside phosphorylase. J Biol Chem. 2003 Aug 22;278(34):31465-8. Epub 2003 Jul 3.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.